Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MNK | Mallinckrodt Plc | -0.28% | 35.97 | 21.1% | $138.29m | |
| PRGO | Perrigo Co. Plc | -1.88% | 74.07 | 6.7% | $126.06m | |
| SHPG | Shire PLC Sponsored ADR | 0.46% | 171.43 | 0.4% | $113.20m | |
| ENDP | Endo International Plc | -1.95% | 15.60 | 8.9% | $89.97m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.16% | 173.97 | 2.2% | $72.74m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 3.50% | 107.00 | 18.7% | $69.26m | |
| SAGE | SAGE Therapeutics, Inc. | 3.81% | 153.87 | 9.6% | $58.93m | |
| UTHR | United Therapeutics Corporation | 2.46% | 128.11 | 14.4% | $52.33m | |
| CTLT | Catalent Inc | 0.70% | 41.58 | 2.6% | $48.31m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 2.41% | 137.49 | 6.8% | $42.64m | |
| PTLA | Portola Pharmaceuticals, Inc. | 1.20% | 25.32 | 7.7% | $42.29m | |
| SUPN | Supernus Pharmaceuticals, Inc. | -0.11% | 44.35 | 6.2% | $40.49m | |
| ICLR | ICON Plc | 1.41% | 143.94 | 4.2% | $39.20m | |
| ZGNX | Zogenix, Inc. | 0.86% | 46.90 | 11.9% | $38.19m | |
| HZNP | Horizon Pharma plc | -0.63% | 20.50 | 7.4% | $33.41m |
Company Profile
Tetraphase Pharmaceuticals, Inc. engages in the development and production of novel antibiotics for serious and life-threatening bacterial infections. It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.